Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent
収録刊行物
-
- Atherosclerosis
-
Atherosclerosis 239 (2), 311-317, 2015-04
Elsevier BV